Acadia Pharmaceuticals (ACAD) Other Non-Current Assets (2016 - 2025)
Historic Other Non-Current Assets for Acadia Pharmaceuticals (ACAD) over the last 17 years, with Q3 2025 value amounting to $9.5 million.
- Acadia Pharmaceuticals' Other Non-Current Assets rose 799.32% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year increase of 799.32%. This contributed to the annual value of $8.8 million for FY2024, which is 5199.31% up from last year.
- According to the latest figures from Q3 2025, Acadia Pharmaceuticals' Other Non-Current Assets is $9.5 million, which was up 799.32% from $9.5 million recorded in Q2 2025.
- Over the past 5 years, Acadia Pharmaceuticals' Other Non-Current Assets peaked at $9.5 million during Q2 2025, and registered a low of $5.8 million during Q1 2021.
- Over the past 5 years, Acadia Pharmaceuticals' median Other Non-Current Assets value was $5.8 million (recorded in 2021), while the average stood at $6.8 million.
- In the last 5 years, Acadia Pharmaceuticals' Other Non-Current Assets crashed by 2894.09% in 2024 and then surged by 6414.21% in 2025.
- Quarter analysis of 5 years shows Acadia Pharmaceuticals' Other Non-Current Assets stood at $5.8 million in 2021, then changed by 0.0% to $5.8 million in 2022, then changed by 0.0% to $5.8 million in 2023, then skyrocketed by 51.99% to $8.8 million in 2024, then rose by 7.99% to $9.5 million in 2025.
- Its Other Non-Current Assets stands at $9.5 million for Q3 2025, versus $9.5 million for Q2 2025 and $8.8 million for Q1 2025.